HIAL
BMY icon

Highland Investment Advisors LLC’s Bristol-Myers Squibb BMY Stock Holding History

Highland Investment Advisors LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4K Buy
+770
New +$44.2K 0.02% 193

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Highland Investment Advisors LLC's BMY Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 770 shares worth $44.4K. The stake represents 0.02% of the portfolio and ranks #193 among its holdings.

2,142 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Highland Investment Advisors LLC held 770 shares of Bristol-Myers Squibb worth $44.4K as of Q2 2026.
  • Bristol-Myers Squibb was a new Highland Investment Advisors LLC position in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #193 holding.
  • 2,142 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.